4.4 Article

Additional conjugation methods and immunogenicity of Bacillus anthracis poly-γ-D-glutarnic acid-protein conjugates

期刊

INFECTION AND IMMUNITY
卷 74, 期 8, 页码 4744-4749

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.00315-06

关键词

-

资金

  1. Intramural NIH HHS Funding Source: Medline

向作者/读者索取更多资源

The capsule of Bacillus anthracis, composed of poly-gamma-D-glutamic acid (gamma DPGA), is an essential virulence factor of B. anthracis. The capsule inhibits innate host defense through its antiphagocytic action. gamma DPGA is a poor immunogen, but when covalently bound to a carrier protein, it elicits serum antibodies. To identify the optimal construct for clinical use, synthetic gamma DPGAs of different lengths were bound to carrier proteins at different densities. The advantages of the synthetic over the natural polypeptide are the homogeneous chain length and end groups, allowing conjugates to be accurately characterized and standardized and their chemical compositions to be related to their immunogenicities. In the present study, we evaluated, in addition to methods reported by us, hydrazone, oxime, and thioether linkages between gamma DPGA and several proteins, including bovine serum albumin, recombinant Pseudomonas aeruginosa exotoxin A, recombinant B. anthracis protective antigen (rPA), and tetanus toxoid (TT). The effects of the dosage and formulation on the immunogenicities of the conjugates were evaluated in mice. All conjugates were immunogenic. The optimal gamma DPGA chain length of 10 to 15 amino acids and the density, an average of 15 mol gamma DPGA per mol of protein, were confirmed. The thioether bond was the optimal linkage type, and TT and rPA were the best carriers. The optimal dosage was 1.2 to 2.5 mu g of gamma DPGA per mouse, and adsorption of the conjugates onto aluminum hydroxide significantly increased the antibody response to the protein with a lesser effect on anti-gamma DPGA levels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据